Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c541 |
|---|---|
| Identifier | NCT06450197 |
| Trial Title | Phase IIa Study Evaluating AZD7798 in Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Moderate to Severe Crohn's Disease |
| Interventions | DRUG: AZD7798|OTHER: Placebo |
Participant Information
| Sponsor | AstraZeneca |
|---|---|
| City | Phoenix |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2024-08-28 |
|---|---|
| Primary Completion Date | 2026-05-01 |
| Completion Date | 2027-05-14 |